Amarin Corp Plc (AMRN)

[HinduKush]

North,
I too hope to see Vascepa included in these trials but we have to realize that the remdesivir population is a very sick one with advanced COVID-19 infection and with multiorgan failure. Thus, it is a big ask to expect Vascepa to save the day. I see a potentially bigger play in seeing if we can find asymptomatic or initially symptomatic serologically confirmed cases and see if we can prevent transmission or progression of disease. I feel this will give an altogether better therapeutic yield for detection of Vascepa benefits.
What is inexplicable to me is the tight lipped super hush - hush approach by both management and scientific leadership with vague allusions to understanding of V’s potential in COVID-19...What are they doing ?
HK